Parathyroid hormone-related peptide (1-36)
Alternative Names: hPTHrP-(1-36); PTHrP-(1-36)Latest Information Update: 24 Sep 2021
At a glance
- Originator Yale University
- Developer Ostotrophin LLC; University of Pittsburgh; Yale University
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant hypercalcaemia; Postmenopausal osteoporosis